Invesco Dynamic Biotechnology & Genome ETF
Save

About

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U. S. biotechnology and genome companies.

Similar securities

Based on sector and market capitalization

Report issue